1. Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Issue 5 (3rd December 2022) Authors: Terhorst‐Molawi, Dorothea; Hawro, Tomasz; Grekowitz, Eva; Kiefer, Lea; Merchant, Kunal; Alvarado, Diego; Thomas, Lawrence J.; Hawthorne, Thomas; Crowley, Elizabeth; Heath‐Chiozzi, Margo; Metz, Martin; Maurer, Marcus Journal: Allergy Issue: Volume 78:Issue 5(2023) Page Start: 1269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗